Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
IM-250 by Innovative Molecules for Simplexvirus (HSV) Infections: Likelihood of Approval
IM-250 is under clinical development by Innovative Molecules and currently in Phase I for Simplexvirus (HSV) Infections. According to GlobalData,...